Ardigen will take part in BioTrinity conference in London, May 8-10, 2017

5 May 2017

BioTrinity is one of Europe’s leading biopartnering and investment conferences, and the largest of its type in the UK.

The aim of BioTrinity is to create an ideal networking and partnering platform for life science companies across the world to meet all under one roof and catalyse business in the industry, to ultimately help shape our healthcare future.

BioTrinity offers unique access to global life science investors, big pharma executives and innovative CEO’s of emerging R&D companies seeking to make deals and grow their networks.

More about BioTrinity

 

Ardigen’s attendance at this conference is subsidized with the funds from the ProBio Małopolska project, which is co-financed by the European Union under the European Regional Development Fund, carried out on the basis of the project co-financing agreement No. RPMP.03.03.01-12-0121 / 16-00. The trip is organized with the assistance of Klaster LifeScience Kraków.